← Back to Search

Behavioral Intervention

Smart Walk App for Physical Activity

Phase 2
Recruiting
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 4-months and 12-months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a smartphone app that is customized for African American women to help them be more active and lower their risk of heart disease and type 2 diabetes.

Who is the study for?
This trial is for African American women who are looking to increase their physical activity to reduce the risk of heart disease and type 2 diabetes. The details on specific eligibility criteria have not been provided.
What is being tested?
The study is testing a 'Smart Walk' program, which uses a smartphone app along with a Fitbit device to encourage more exercise. It's designed specifically for African American women and aims at improving their health by making them less sedentary.
What are the potential side effects?
Since this intervention involves physical activity, potential side effects may include muscle soreness, fatigue, or injury from exercise. However, these are common when starting any new workout routine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 4-months and 12-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 4-months and 12-month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in accelerometer-measured moderate-to-vigorous intensity physical activity from baseline to 4- and 12-months
Change in self-reported moderate-to-vigorous intensity physical activity from baseline to 4- and 12-months
Secondary study objectives
Change in aortic pulse wave velocity from baseline to 4- and 12-months
Change in behavioral capability for physical activity from baseline to 4- and 12-months
Change in blood pressure (mmHG) from baseline to 4- and 12-months
+16 more
Other study objectives
Cost-effectiveness
Objectively-measured home neighborhood characteristics
Participant costs
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smart WalkExperimental Treatment1 Intervention
Participants will receive a culturally tailored smartphone-delivered physical activity intervention.
Group II: FitbitActive Control1 Intervention
Participants will receive a Fitbit Inspire 3 activity monitor.

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
298 Previous Clinical Trials
107,697 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,928 Previous Clinical Trials
47,764,933 Total Patients Enrolled
~160 spots leftby Mar 2027